Erythromycin Pellets

(Product under development)
Erythromycin PelletsErythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins.

For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasmaand Legionellosis.

In structure, this macrocyclic compound contains a 14-membered lactone ring with ten asymmetric centers and two sugars (L-cladinose and D-desosamine), making it a compound very difficult to produce via synthetic methods.

Erythromycin is produced from a strain of the actinomycete Saccharopolyspora erythraea.

Available Form:
Erythromycin Pellets
Erythromycin Granules

Umang Pharmatech equipments used for production of Erythromycin Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Erythromycin Pellets
Systematic (IUPAC) Name
Erythromycin Pellets
Identifiers
Erythromycin Pellets
Chemical data
(3R,4S,5S,6R,7R,9R,11R,12R,13S,
14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)
-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
CAS number : 114-07-8
ATC code : AF02 J01FA01 S01AA17QJ51FA01
PubChem : CID 3255
DrugBank : DB00199
ChemSpider : DB00199
UNII : 63937KV33D
KEGG : D00140
ChEMBL : D00140
Formula : C37H67NO13
Mol. mass : 733.93 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL